CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing targeted therapies for prostate cancer by utilizing ligand-drug conjugates that disrupt specific calcium signaling pathways in cancer cells. The goal is to enhance treatment efficacy while minimizing side effects.
Cancer remains a leading cause of death and morbidity worldwide.
Prostate cancer (PC) is among the most frequently diagnosed non-skin cancers.
Despite major advances in the understanding of cancer biology and development of candidate therapeutic agents, there is still an urgent need of exploiting innovative chemotypes and disrupting novel signalling pathways.
Evidence suggests that targeted therapies may provide an original means of selectively modulating diseased prostate cells.
Herein we propo…
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
